JHJieyue He

Jieyue He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jieyue He has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Synergistic Multi-Drug Combination Prediction Based on Heterogeneous Network Representation Learning with Contrastive Learning

    by Xin Xi, Jinhui Yuan, Shan Lu, Jieyue He

    The combination of multiple drugs is a significant therapeutic strategy that can enhance treatment effectiveness and reduce medication side effects. However, identifying effective synergistic drug combinations in a vast search space remains challenging. Current methods for predicting synergistic drug combinations primarily rely on calculating drug similarity based on the drug heterogeneous network or drug information, enabling the prediction of pairwise synergistic drug combinations. However, these methods not only fail to fully study the rich information in drug heterogeneous networks, but also can only predict pairwise drug combinations. To address these limitations, we present a novel Synergistic Multi-drug Combination prediction method of Western medicine based on Heterogeneous Network representation learning with Contrastive Learning, called SMC-HNCL. Specifically, two drug features are learnt from different perspectives using the drug heterogeneous network and anatomical therapeutic chemical (ATC) codes, and fused by attention mechanism. Furthermore, a group representation method based on multi-head self-attention is employed to learn representations of drug combinations, innovatively realizing the prediction of synergistic multi-drug combinations. Experimental results demonstrate that SMC-HNCL outperforms the state-of-the-art baseline methods in predicting synergistic drug pairs on two synergistic drug combination datasets and can also effectively predict synergistic multi-drug combinations.


  • Open Access

    MultiModal-Learning for Predicting Molecular Properties: A Framework Based on Image and Graph Structures

    by Zhuoyuan Wang, Jiacong Mi, Shan Lu, Jieyue He

    The quest for accurate prediction of drug molecule properties poses a fundamental challenge in the realm of Artificial Intelligence Drug Discovery (AIDD). An effective representation of drug molecules emerges as a pivotal component in this pursuit. Contemporary leading-edge research predominantly resorts to self-supervised learning (SSL) techniques to extract meaningful structural representations from large-scale, unlabeled molecular data, subsequently fine-tuning these representations for an array of downstream tasks. However, an inherent shortcoming of these studies lies in their singular reliance on one modality of molecular information, such as molecule image or SMILES representations, thus neglecting the potential complementarity of various molecular modalities. In response to this limitation, we propose MolIG, a novel MultiModaL molecular pre-training framework for predicting molecular properties based on Image and Graph structures. MolIG model innovatively leverages the coherence and correlation between molecule graph and molecule image to execute self-supervised tasks, effectively amalgamating the strengths of both molecular representation forms. This holistic approach allows for the capture of pivotal molecular structural characteristics and high-level semantic information. Upon completion of pre-training, Graph Neural Network (GNN) Encoder is used for the prediction of downstream tasks. In comparison to advanced baseline models, MolIG exhibits enhanced performance in downstream tasks pertaining to molecular property prediction within benchmark groups such as MoleculeNet Benchmark Group and ADMET Benchmark Group.

  • Open Access

    AGHINT: Attribute-Guided Representation Learning on Heterogeneous Information Networks with Transformer

    by Jinhui Yuan, Shan Lu, Peibo Duan, Jieyue He

    Recently, heterogeneous graph neural networks (HGNNs) have achieved impressive success in representation learning by capturing long-range dependencies and heterogeneity at the node level. However, few existing studies have delved into the utilization of node attributes in heterogeneous information networks (HINs). In this paper, we investigate the impact of inter-node attribute disparities on HGNNs performance within the benchmark task, i.e., node classification, and empirically find that typical models exhibit significant performance decline when classifying nodes whose attributes markedly differ from their neighbors. To alleviate this issue, we propose a novel Attribute-Guided heterogeneous Information Networks representation learning model with Transformer (AGHINT), which allows a more effective aggregation of neighbor node information under the guidance of attributes. Specifically, AGHINT transcends the constraints of the original graph structure by directly integrating higher-order similar neighbor features into the learning process and modifies the message-passing mechanism between nodes based on their attribute disparities. Extensive experimental results on three real-world heterogeneous graph benchmarks with target node attributes demonstrate that AGHINT outperforms the state-of-the-art.

  • Open Access

    RoKEPG: RoBERTa and Knowledge Enhancement for Prescription Generation of Traditional Chinese Medicine

    by Hua Pu, Jiacong Mi, Shan Lu, Jieyue He

    Traditional Chinese medicine (TCM) prescription is the most critical form of TCM treatment, and uncovering the complex nonlinear relationship between symptoms and TCM is of great significance for clinical practice and assisting physicians in diagnosis and treatment. Although there have been some studies on TCM prescription generation, these studies consider a single factor and directly model the symptom-prescription generation problem mainly based on symptom descriptions, lacking guidance from TCM knowledge. To this end, we propose a RoBERTa and Knowledge Enhancement model for Prescription Generation of Traditional Chinese Medicine (RoKEPG). RoKEPG is firstly pre-trained by our constructed TCM corpus, followed by fine-tuning the pre-trained model, and the model is guided to generate TCM prescriptions by introducing four classes of knowledge of TCM through the attention mask matrix. Experimental results on the publicly available TCM prescription dataset show that RoKEPG improves the F1 metric by about 2% over the baseline model with the best results.

  • Open Access

    ACDNet: Attention-guided Collaborative Decision Network for Effective Medication Recommendation

    by Jiacong Mi, Yi Zu, Zhuoyuan Wang, Jieyue He

    Medication recommendation using Electronic Health Records (EHR) is challenging due to complex medical data. Current approaches extract longitudinal information from patient EHR to personalize recommendations. However, existing models often lack sufficient patient representation and overlook the importance of considering the similarity between a patient's medication records and specific medicines. Therefore, an Attention-guided Collaborative Decision Network (ACDNet) for medication recommendation is proposed in this paper. Specifically, ACDNet utilizes attention mechanism and Transformer to effectively capture patient health conditions and medication records by modeling their historical visits at both global and local levels. ACDNet also employs a collaborative decision framework, utilizing the similarity between medication records and medicine representation to facilitate the recommendation process. The experimental results on two extensive medical datasets, MIMIC-III and MIMIC-IV, clearly demonstrate that ACDNet outperforms state-of-the-art models in terms of Jaccard, PR-AUC, and F1 score, reaffirming its superiority. Moreover, the ablation experiments provide solid evidence of the effectiveness of each module in ACDNet, validating their contribution to the overall performance. Furthermore, a detailed case study reinforces the effectiveness of ACDNet in medication recommendation based on EHR data, showcasing its practical value in real-world healthcare scenarios.

  • Open Access

    Hybrid attentional memory network for computational drug repositioning

    by Jieyue He, Xinxing Yang, Zhuo Gong, Lbrahim Zamit

    Background: Drug repositioning has been an important and efficient method for discovering new uses of known drugs. Researchers have been limited to one certain type of collaborative filtering (CF) models for drug repositioning, like the neighborhood based approaches which are good at mining the local information contained in few strong drug–disease associations, or the latent factor based models which are effectively capture the global information shared by a majority of drug–disease associations. Few researchers have combined these two types of CF models to derive a hybrid model which can offer the advantages of both. Besides, the cold start problem has always been a major challenge in the field of computational drug repositioning, which restricts the inference ability of relevant models.Results: Inspired by the memory network, we propose the hybrid attentional memory network (HAMN) model, a deep architecture combining two classes of CF models in a nonlinear manner. First, the memory unit and the attention mechanism are combined to generate a neighborhood contribution representation to capture the local structure of few strong drug–disease associations. Then a variant version of the autoencoder is used to extract the latent factor of drugs and diseases to capture the overall information shared by a majority of drug–disease associations. During this process, ancillary information of drugs and diseases can help alleviate the cold start problem. Finally, in the prediction stage, the neighborhood contribution representation is coupled with the drug latent factor and disease latent factor to produce predicted values. Comprehensive experimental results on two data sets demonstrate that our proposed HAMN model outperforms other comparison models based on the AUC, AUPR and HR indicators.Conclusions: Through the performance on two drug repositioning data sets, we believe that the HAMN model proposes a new solution to improve the prediction accuracy of drug–disease associations and give pharmaceutical personnel a new perspective to develop new drugs.